Abvc BioPharma
(NASDAQ) ABVC
Abvc BioPharma Financials at a Glance
Market Cap
$34.84M
Revenue (TTM)
-$795.95K
Net Income (TTM)
-$9.42M
EPS (TTM)
-$0.39
P/E Ratio
-3.44
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$1.35
Volume
77,636
Open
$1.38
Price
$1.35
Volume
77,636
Open
$1.38
Previous Close
$1.34
Daily Range
$1.32 - $1.38
52-Week Range
$0.88 - $5.48
Estimated Earnings Date
Aug 18, 2026
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$1.35
Volume
77,636
Open
$1.38
Previous Close
$1.34
Daily Range
$1.32 - $1.38
52-Week Range
$0.88 - $5.48
Estimated Earnings Date
Aug 18, 2026
ABVC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Abvc BioPharma
Industry
Biotechnology
Sector
Health CareEmployees
19
CEO
Uttam Yashwant Patil, PhD
Website
www.abvcpharma.comHeadquarters
Fremont, CA 94538, US
ABVC Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
11%
Net Income Margin
12%
Return on Equity
-107%
Return on Capital
-62%
Return on Assets
-48%
Earnings Yield
-29.07%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$34.84M
Shares Outstanding
26.00M
Volume
77.64K
Avg. Volume
108.72K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$7.15M
EBITDA
-$7.43M
Operating Cash Flow
-$2.99M
Capital Expenditure
$0.00
Free Cash Flow
-$2.99M
Cash & ST Invst.
$745.83K
Total Debt
$3.47M
Abvc BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$34.84M
N/A
Market Cap/Employee
$2.18M
N/A
Employees
16
N/A
Net Income
-$1.56M
-85.3%
EBITDA
-$1.55M
-155.0%
Quarterly Fundamentals
Net Cash
-$2.53M
-16.8%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
-100.0%
Long Term Debt
$1.51M
+804.8%
Short Term Debt
$1.22M
-56.8%
Return on Assets
-47.75%
N/A
Return on Invested Capital
-61.56%
N/A
Free Cash Flow
-$894.24K
-65.7%
Operating Cash Flow
-$894.24K
-65.7%